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Summary 
A modular approach for balanced overexpression of recombinant multiprotein complexes in 
E. coli is described, with the prokaryotic protein secretase/insertase complex, the SecYEG-
SecDFYajC-YidC holotranslocon (HTL) used as an example.  This procedure has been 
implemented here in the ACEMBL system. The protocol details the design principles of the 
mono- or polycistronic DNA constructs, the expression and purification of functional HTL 
and its association with translating ribosome nascent chain (RNC) complexes into a RNC-
HTL supercomplex.   
1. Introduction 
About a third of the proteome in living cells is integrated into or transported across 
membranes, catalyzed by the ubiquitous Sec machinery which is conserved in all kingdoms 
of life. In prokaryotes, the Sec machinery contains the core translocon, SecYEG. Regulatory 
subunits including SecDF, YajC and YidC can associate with the core translocon giving rise 
to the SecYEG-SecDFYajC-YidC holotranslocon complex (1-4). All subunits in this 
heptameric holotranslocon are transmembrane proteins (3,5). 
Heterologous expression has been instrumental to advance protein research in the life 
sciences, and E. coli has largely dominated the field of recombinant expression, a trend which 
remains unbroken to date, although mammalian and insect cell based eukaryotic expression 
systems have been making their impressive mark more recently (6-9). E. coli remains 
unsurpassed as a simple and cost effective expression host for protein production, and a very 
large number of plasmids and host strains are conveniently available to the research 
community for recombinant expression in this prokaryotic system.  
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In living cells, the catalysts of biological activity are typically not single, isolated 
proteins, but protein complexes which can contain many different subunits (10,11). Many 
complexes are characterized by low abundance and heterogeneity in their native hosts, which 
is refractory to their extraction from native source material, and necessitates recombinant 
overexpression to purify them in sufficient amounts for detailed mechanistic studies. The 
SecYEG-SecDFYajC-YidC holotranslocon transmembrane protein complex, HTL, has been 
discovered in E. coli membranes, where it catalyzes the transport of membrane-bound or 
periplasmic proteins as they emerge from the actively translating ribosome (3-5, 12-14). A 
particular challenge in expressing functional complexes such as HTL can be encountered 
when many heterologous subunits are co-produced from individual expression cassettes, 
resulting in imbalanced expression levels of the individual proteins and impedes proper 
complex assembly. Certain subunits can be expressed either more weakly of strongly, and, 
occasionally, one subunit may dominate the recombinant overexpression experiment to a 
degree that it becomes detrimental to overall yield. As a consequence, a complex containing 
all subunits at their physiological stoichiometric ratios cannot be obtained. Moreover, the 
HTL consists of assembly blocks which by themselves can form stable entities (SecYEG, 
SecDF and YidC), further complicating HTL production and purification as a homogeneous, 
functional assembly, prenecessitating elaborate promoter and expression cassette design, tag 
placement and systematic trial-and-error to achieve success (13-15).  Originally, only six 
subunits (SecYEG, SecDF and YidC) were thought to be present in HTL and thus included in 
the overexpression experiments (15). Later, a seventh subunit, YajC, was identified and 
added to the overexpression setup to yield complete, functional and stable heptameric HTL 
(12-14).  
In order to meet these challenges and to produce and purify HTL in the quality and 
quantity required for detailed study, we developed ACEMBL, a modular overexpression 
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system for protein complex expression in E. coli (Fig. 1) (15-17). ACEMBL affords the 
means to assemble mono- or polycistronic expression cassettes to optimally balance 
expression levels and achieve properly assembled complexes with correct subunit 
stoichiometry. ACEMBL consists of small, custom designed expression plasmids containing 
all elements required for expressing recombinant proteins in E. coli as an expression host 
(Fig. 1). Two families of plasmids exist, Acceptors and Donors (Fig. 1). Acceptors and 
Donors can each contain one or several genes of interest, arranged in (i) single gene 
expression cassettes consisting of a promoter, a gene and a transcriptional terminator, or (ii) 
in the form of polycistrons where several genes are transcribed from the same promoter, or a 
combination of both (15). Donors and Acceptors, each containing one or several genes of 
interest, are conveniently fused by Cre recombinase to yield Donor-Acceptor fusions which 
contain all genes that need to be co-produced. Promoters, genes and terminators are in 
BioBrick design (18) and exchangeable in the individual Donors and Acceptors, a feature 
which enabled us to test the best combinations for producing functional HTL in parallel by 
trial and error within a reasonable timeframe until a suitable HTL expression construct was 
identified (Fig. 2). ACEMBL can be implemented in a robotics environment (15, 16), 
however, for most applications in our laboratory (including HTL) production, the manual 
approach, optionally with a multichannel pipette, is sufficient to achieve success. We have 
described earlier the conceptual use of ACEMBL to generate HTL expression constructs (13-
15). In the present contribution, we describe the principle of HTL multigene expression 
construct assembly which can be used as a blueprint for other transmembrane or soluble 
complexes. We highlight important considerations for the production and purification of 
functional HTL (Fig. 3), and describe the assembly of HTL with actively transcribing 
ribosome nascent chain complexes (RNCs) into a RNC-HTL supercomplex (Fig. 4). 
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2. Materials 
We strongly recommend carrying out the design of all expression constructs in silico using a 
DNA cloning software of choice (i.e. VectorNTI, ApE, others). Gene synthesis has become 
very affordable, and we prefer synthetic genes for generating the individual genes of interest, 
in which internal restriction sites for subcloning into the ACEMBL Donor and Acceptor 
plasmids are eliminated by design. We also recommend codon optimization for expression of 
the genes of interest, which is a service provided at no cost from synthetic DNA suppliers, 
and typically includes removal of potentially problematic RNA secondary structure elements 
in the transcripts. If synthetic genes are used, we further recommend to additionally eliminate 
any restriction sites that are part of the so-called multiplication modules in the plasmids (15, 
16). This allows for maximum flexibility of gene assembly for co-expression (e.g. if 
purification tag placement needs to be revised in later iterations). The modular concept of 
ACEMBL furthermore allows transferring expression cassettes between various plasmids 
(15).  
All reagents are prepared using ultrapure water (Millipore Milli-Q system or 
equivalent; conductivity of 18.2 MΩ∙cm at 25°C) and analytical grade reagents. Buffers, 
antibiotics and enzymes are stored at -20°C.  
2.1 Generation of Donor and Acceptor plasmids for HTL subassemblies 
1. Restriction endonucleases and reaction buffers (New England Biolabs, NEB) 
2. T4 DNA ligase and buffer (NEB)  
3. Gel extraction kit (i.e. Qiagen, Germany) 
4. Plasmid purification kit (i.e. Qiagen, Germany) 
5. Regular E. coli competent cells (TOP10, HB101, or comparable). 
6. E. coli competent cells containing pir gene (for Donor plasmids) 
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7. Antibiotics ampicillin, chloramphenicol, spectinomycin (for concentrations see Ref. 
15) 
8. Agar for pouring plates 
9. Media (LB, TB, SOC) for growing minicultures 
2.2 Materials for generating multigene Donor-Acceptor fusions expressing complete 
HTL 
1. E. coli competent cells (TOP10, HB101, or comparable) 
2. Cre recombinase enzyme (New England Biolabs, NEB) 
3. Antibiotics ampicillin, chloramphenicol, spectinomycin (for concentrations see Ref. 
15) 
4. Agar for pouring plates 
5. Media (LB, TB, SOC) for growing minicultures 
2.3 Materials for producing HTL 
1. E. coli competent cells C43(DE3) 
2. ACEMBL:holo-translocon (HTL) multigene expression plasmid encoding for YidC, 
SecYEG, SecDF and YajC fitted with appriopriate affinity purification tags (13, 14), 
3.  2xYT broth with antibiotics ampicillin, chloramphenicol, kanamycin 
4. Isopropyl -D-1-thiogalactopyranoside IPTG  (Sigma Aldrich) 
5. L-(+)-arabinose (>99%, Sigma Aldrich) 
6. Cell disruptor (Constant Systems, Ltd) 
7. TSG130 buffer [20mM Tris-Cl (pH 8.0), 130mM NaCl, 10% v/v glycerol] 
8. n-dodecyl--D-maltoside (DDM, Sigma Aldrich) 
9. Chelating Ni2+-Sepharose Fast Flow column (GE Healthcare) 
10. Superdex 200, 26/60 gel filtration column (GE Healthcare) 
11. Q-Sepharose ion exchange column (GE Healthcare) 
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12. 50-kDa-molecular-weight cutoff centrifugation fliter (Amicon) 
2.4. Materials for preparing HTL-ribosome nascent chain supercomplex 
1. Purified ribosome nascent chain (RNC) complexes comprising a 108-amino acid long 
FtsQ nascent chain with a signal sequence (detailed preparation protocol see Ref 
Schaffitzel/Ban.)  
2. DDM solubilized purified HTL. 
 
 
3. Methods 
The genes encoding for the individual subunits are designed in silico, and then inserted into 
the Donor and Acceptor plasmid of choice. Once designed, mono- or polycistronic expression 
cassettes can be created by a variety of means including DNA synthesis, restriction/ligation 
cloning, ligation independent cloning (LIC) or sequence and ligation independent cloning 
(SLIC) or other methods (19, 20), according to individual user preference. We recommend 
custom DNA synthesis to facilitate expression cassette construction, in particular if 
polycistronic expression cassettes are used as in the case of HTL.  
3.1 In silico design 
1. Group genes into functional units based on a set of criteria (known interaction 
partners, physiological (sub)assemblies, here YidC, SecYEG, SecDF and YajC). 
GenBank identifiers for HTL subunits are: SecY, WP_001118868.1; SecE, 
WP_001275702.1; SecG, AAN82372.1; SecD, ODA87210.1; SecF, AAN78997.1; 
YidC, WP_000378250.1; YajC, WP_000007629.1. 
2. Decide on the number of expression cassettes to be co-expressed and the Donor and 
Acceptor plasmids you plan to use. 
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3. Decide on placement of tags and, optionally, on proteolytic sites to remove them (we 
recommend Tobacco etch virus (TEV) NIa protease and/or precision protease). 
4. Decide on the use of polycistrons or individual expression cassettes, and the 
promoters to be tested. These can be the promoters provided by the standard 
ACEMBL plasmids (T7, lac), or include different promoters, as in the case of HTL, 
for example arabinose and trc promoters. 
5. Generate the DNA sequence. Decide on DNA assembly strategy (SLIC, 
restriction/ligation, PCR assembly, others). Add custom restriction sites to 5’ and 3’ 
ends which are compatible with the polylinkers in the Donor and Acceptor plasmids 
in case you use restriction/ligation-based cloning. 
6. Create all DNA sequences in silico and validate by simulating the reading frame in the 
in silico plasmid sequences. 
3.2 Preparation of Donor and Acceptor plasmids 
1. Choose from ACEMBL system components pACE1, pACE2, pDK, pDC, pDS to 
generate the expressing construct of choice. If promoters other than those already 
present on the original plasmids (T7, lac) are to be used, we recommend to create the 
‘empty’ expression cassette first in the format promoter-polylinker-terminator, 
substitute the original expression cassette, and keep the resulting new Donor or 
Acceptor plasmid, fitted with the preferred promoter, in stock for future expressions 
of different complexes. All ACEMBL plasmids contain a LoxP site for generating 
Donor-Acceptor fusions by Cre recombinase. In the case of the HTL expression, an 
arabinose promoter (controlling a YidC-SecDF polycistron) and two trc promoters  
(controlling the SecYEG polycistron or the YajC gene, respectively),  resulted in the 
construct yielding properly assembled complex (13, 14).   
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2. Digest several micrograms Donor or Acceptor plasmid by the restriction enzymes 
selected by in silico design according to manufacturers’ recommendation.  
3. Analyze the digestions by agarose gel electrophoresis to confirm that the digestions 
are complete. 
4. Purify digested plasmid by using commercial gel extraction kits (for example Qiagen 
gel extraction kit). Elute the extracted DNA in the minimal volume defined by the 
manufacturer. Determine the concentration of the extracted DNA 
spectrophotometrically (e.g. Thermo Scientific NanoDrop 2000). Store in frozen 
aliquots. 
 
3.3 Inserting genes into digested Donor or Acceptor 
1. Digest several micrograms of the DNA (generated by DNA synthesis, SLIC, PCR 
assembly or other method of choice) encoding for the desired individual gene or 
polycistron (the ‘insert’) with the enzymes identified by in silico design, according to 
the manufacturers’ recommendation. For polycistron generation, follow the guidelines 
and protocols in Ref. 15) 
2. Purify digested insert DNA by using a commercial gel extraction kit. Elute the 
extracted DNA in the minimal volume defined by the manufacturer. Determine the 
concentration of the extracted DNA spectrophotometrically (e.g. Thermo Scientific 
NanoDrop 2000). 
3. Set up ligation reactions by mixing purified insert and digested and gel extracted 
Donor or Acceptor, respectively  (see Subheading 3.2) in 10-20 µL reaction volume 
with T4 DNA ligase and perform ligation reactions at 25ºC overnight. Optionally, 
analyze the ligation reaction by agarose gel electrophoresis to evaluate the ligation 
efficiency. 
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4. Transform E. coli competent cells (TOP10 or HB101 for Acceptors, pir gene 
containing cells for Donors; see Note 1) with ligation reaction mixture. Incubate the 
transformation reaction in a 37°C shaker for several hours and plate on agar plates in 
a dilution series to ensure optimal colony separation. 
5. Pick colonies, grow minicultures and purify plasmids using standard procedures.  
6. Identify positive clones by restriction digestion and DNA sequencing of the insert. 
3.4 Cre-LoxP fusion of Donors and Acceptor  
1. Prepare 20 ul reaction mixture for Cre reaction by combining 100 ng each of Donor 
and Acceptor plasmids. Add Cre enzyme and Cre buffer according to the 
recommendations of the supplier. Incubate at 30°C.  Transform regular E. coli 
competent cells (TOP10, HB101, or comparable) with Cre reaction mixcture 
following standard transformation protocols. Incubate the transformation reaction in a 
37°C shaker for one or several hours. 
2. Plate the transformation reaction on agar plates containing the proper antibiotics 
combination (for HTL: ampicillin, chloaramphenicol, kanamycin). Incubate at 37°C 
over night. 
3. Pick colonies and inoculate 25 mL aliquots of LB medium supplemented with 
corresponding antibiotics. After overnight incubation, prepare Acceptor-Donor fusion 
plasmid using standard kits (Qiagen). Predict Acceptor-Donor fusion plasmid 
sequence by using web-based Cre-ACEMBLER software (21). Check plasmids by 
restriction digestion using appropriate enzymes identified by restriction pattern 
prediction (see Note 2).  
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3.5 Producing recombinant HTL 
1. Grow freshly transformed E. coli C43(DE3) with ACEMBL plasmid encoding for 
HTL (Fig. 2) in 2xYT broth with antibiotics to OD600 = 0.8. 
2. Induce for 3h by adding 1 mM IPTG and 0.2% (wt/vol) arabinose.  
3. Pellet cells by centrifugation and break cells at 25 kpsi with cell disruptor in TSG130 
buffer. 
4. Collect membrane fraction containing HTL and solubilize by rotation in TSG130 
containing 2% (wt/vol) DDM for 1h at 4°C.  
5. Clarify DDM-soluble fraction by centrifugation and purify by using Ni2+ metal 
affinity chromatography (column pre-equilibrated in TSG130 containing 0.1% DDM). 
6. Wash column thoroughly (10 column volumes) with buffer containing 30 mM 
imidazole. 
7. Elute bound HTL with buffer containing 500 mM imidazole. 
8. Pool peak fractions and purify immediately using a S200 size exclusion column, 
placed in-line with a Q-Sepharose column equilibrated in TSG130 + 0.05% DDM. 
9. Pool peak fractions and concentrate (50kDa cutoff Amicon filter). 
10. Concentrate to 5-10mg/ml (molar extinction coefficient: HTL = 497,000 M-1cm-1 
(13). 
3.6 Assembling RNC-HTL supercomplex 
1. Mix DDM-solubilized HTL and purified RNCFtsQ in a 25:1 molar ratio. 
2. Isolate resulting RNCFtsQ-HTL supercomplex by sedimentation centrifugation through 
a sucrose cushion to separate unbound HTL from ribosome associated HTL as 
described earlier for the core translocon, SecYEG, bound to RNC (21). 
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4. Notes 
1. Donors and their derivatives can only be propagated in cells that express the pir gene 
(such as BW23473, BW23474, or PIR1 and PIR2, Invitrogen) due to the conditional 
origin present on these plasmids (23). In contrast, Acceptors and their derivatives 
contain regular ColE1 origin of replication and can be propagated in regular E. coli 
strains (TOP10, HB101, or comparable). 
2. Cre-ACEMBLER application software can be downloaded from 
https://github.com/christianbecke/Cre-ACEMBLER/downloads/.  
Accompanying information can be downloaded from 
www.embl.fr/multibac/multiexpression_technologies/cre-acembler/. 
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Figure Legends: 
Figure 1. ACEMBL system components. (A) ACEMBL consists of Donor (pDC, pDK, 
pDS) and Acceptor (pACE) plasmids into each of which one or several genes, optionally as 
polycistrons, can be inserted by a variety of cloning routines. Ap, ampicillin; Cm, 
chloramphenicol; Kn, kanamycin; Sp, spectinomycin. R6K, phage-derived conditional 
origin of replication; BR322, regular E. coli replicon. Transcriptional terminators are 
indicated as boxes filled in black. A multiplication modules is shown as boxes filled in blue. 
LoxP sequences are indicated as circles filled in red. T7 and Lac promoters are shown as 
triangles filled in black or grey, respectively. Promoters and terminators can be exchanged to 
different promoters (ara, trc, others) if needed. MIE stands for multi-integration element and 
indicates a polylinker that facilitates polycistron assembly (15). (B) Cre-LoxP mediated 
fusion of one or several Donors with an Acceptor, each carrying one or several expression 
cassettes of interest, results in multigene expression constructs for protein complex 
production (diagram adapted from Ref. 16). The Cre reaction is an equilibrium reaction with 
the excision reaction being preferred over fusion. When equilibrium is reached, Donor and 
Acceptor plasmids co-exist with higher order multigene fusion constructs (AD, ADD, …). 
All DNA entities, educts and products, present in the Cre reaction are quasi bar-coded by 
their resistance marker combinations and cen be identified by transformation and subsequent 
challenge with antibiotics (15).   
Figure 2: The ACEMBL HTL expression construct. The hexa-histidine tags and the 
calmodulin-binding peptide (CBP) tag are marked in red and orange respectively (image 
adapted from Ref. 13). ara, arabinose promoter, trc, modified, tight lac promoter. LoxP sites 
are depicted as circles filled in grey, transcriptional terminators are shown as boxes filled in 
black.  
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Figure 3: Purification of the E. coli HTL. (A) Representative gel filtration/ion exchange 
elution profile of the HTL evidencing a single peak, demonstrating the copurification of all 
HTL subunits in a single complex. (B) SDS-PAGE analysis of peak fractions 16–24 
(corresponding to elution volumes of the profile displayed in A marked by dotted lines). The 
asterisk represents a proteolytic break-down fragment of SecY. 
Figure 4: HTL-RNC supercomplex. (A) Interaction of the HTLDDM with ribosome nascent 
chain complexes (RNC) analysed by sedimentation experiments and SDS-PAGE. Molecular 
weight marker is shown on the left. Commassie stained protein bands corresponding to HTL 
components are marked on the right. (B) Atomic model of the ribosome-SecYEG complex 
fitted into a preliminary cryo-EM structure of the RNCFtsQ-HTLDDM complex. The density of 
the HTL is larger than SecYEG alone, and an additional strong connection to the ribosome 
was identified (indicated by the red arrow). 
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